Evidence map›Paper›PMID 36964608›Full record

ArticleAddiction science & clinical practice2023

Study design to evaluate a web-intervention to prevent alcohol and cannabis-impaired driving and use among adolescents in driver education.

Karen Chan Osilla, Elizabeth J D'Amico, Rosanna Smart, Anthony Rodriguez, Katherine Nameth, Justin Hummer

Registry-linked trialOpen access · goldFull text readEvaluation Study
In one paragraph

Article in Addiction science & clinical practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04959461 (A Pilot Trial to Prevent Intoxicated and Impaired Driving Among Adolescents), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04959461 nacompletednot on this map

A Pilot Trial to Prevent Intoxicated and Impaired Driving Among Adolescents

TypeinterventionalSponsorStanford UniversityRan2022 to 2025Enrolled198ConditionsSubstance-Related DisordersArmswebCHAT, Usual Care
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Karen Chan OsillaDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Palo Alto, CA, 94305, USA. kosilla@stanford.edu.ORCID 0000-0002-6222-5833
Elizabeth J D'AmicoRAND Corporation, 1776 Main Street, PO Box 2136, Santa Monica, CA, 90407‑2138, USA.
Rosanna SmartRAND Corporation, 1776 Main Street, PO Box 2136, Santa Monica, CA, 90407‑2138, USA.
Anthony RodriguezRAND Corporation, 20 Park Plaza # 920, Boston, MA, 02116, USA.
Katherine NamethDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Palo Alto, CA, 94305, USA.
Justin HummerRAND Corporation, 1776 Main Street, PO Box 2136, Santa Monica, CA, 90407‑2138, USA.
RAND Corporation · USStanford University · US

Funding

A Pilot Trial to Prevent Intoxicated and Impaired Driving Among AdolescentsR34AA027689 · NIAAA · STANFORD UNIVERSITY · PI OSILLA, KAREN CHAN · 2019 to 2021
$620k
NIAAA NIH HHS R34 AA027689
6 · The paper itself

Abstract

backgroundAlcohol and cannabis are the most commonly used substances among adolescents in the U.S. The consequences related to using both substances together are significantly higher relative to use of either substance alone. Teens' propensity to engage in risky driving behaviors (e.g., speeding, rapid lane changes, and texting) and their relative inexperience with the timing and duration of cannabis' effects puts them at heightened risk for experiencing harms related to driving under the influence. Use of alcohol and cannabis peak at age 16, the legal age teens may apply for a provisional driver's license in some states. Targeting novice teen drivers prior to licensure is thus an ideal time for prevention efforts focused on reducing alcohol and/or cannabis initiation, use, and impaired driving.

methodsThe current study proposes to evaluate the efficacy of webCHAT among 15.5 to 17-year-old adolescents (n = 150) recruited at driver education programs. WebCHAT is a single session online intervention that aims to prevent alcohol and cannabis use and risky driving behaviors. We will recruit adolescents enrolled in driver education programs, and stratify based on whether they used cannabis and/or alcohol in the past 3 months (60% screening negative and 40% screening positive). All participants will receive usual driver education and half will also receive webCHAT. We will test whether webCHAT in addition to usual driver education reduces alcohol and/or cannabis initiation or use and reduces risky driving attitudes and behaviors (intent to drive after drinking/using, riding as a passenger with someone who drank/used) compared to teens in usual driver education over a 6-month period. We will also explore whether variables such as beliefs and perceived norms serve as explanatory mechanisms for our outcomes. DISCUSSION: The study has the potential to promote public welfare by decreasing adolescent initiation and use of cannabis and alcohol and reducing risky driving behaviors that can have substantial monetary, personal, and social costs. The study recruits adolescents who are at risk for substance use as well as those who are not and it is delivered remotely during a teachable moment when adolescents receive driver education. Trial registration This study was registered with ClinicalTrials.gov on July 13, 2021 (NCT04959461). https://clinicaltrials.gov/ct2/show/NCT04959461.

Indexed as

Automobile DrivingCannabisSubstance-Related DisordersAdolescentHumansResearch DesignRisk-TakingAdolescentsAlcoholCannabisImpaired drivingMarijuanaPreventionWeb intervention

Identifiers

PMID36964608
PMCPMC10037905
OpenAlexW4360865702

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read11
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.